John H. Eldridge
Chief Tech/Sci/R&D Officer at Profectus BioSciences, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey N. Meshulam | M | - |
Profectus BioSciences, Inc.
 Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD.
State University of New York at Buffalo
| 24 years |
| J. Barry Mason | M | 83 |
The University of Alabama
| 36 years |
| William A. Haseltine | M | 79 |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | - |
| Frederick C. Tecce | M | 86 |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | - |
| M. G. Sarngadharan | M | - |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | - |
| Michael A. Egan | M | - |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | 16 years |
| David Karl Clarke | M | 69 |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | 16 years |
| Alan M. Gordon | M | - |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | 14 years |
| Michael I. Greenebaum | M | - |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | - |
| Terry Lierman | M | - |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | - |
| Marc Tremblay | M | - |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | 16 years |
| Steve Udem | M | - |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | - |
| Andrew Murdin | M | - |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Gerard Lynch | M | 67 |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | 14 years |
| Shawn O'Brien | M | - |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | 2 years |
| Neil Leibman | M | 64 |
State University of New York at Buffalo
| 4 years |
| John P. Maloney | M | - |
The University of Alabama
| 6 years |
| Darryl Roberts | M | 62 |
The University of Alabama
| 7 years |
| Danny Despot | M | - |
The University of Alabama
| 5 years |
| Douglas Reif | M | 70 |
State University of New York at Buffalo
| 6 years |
| Gary P. Jacobi | M | - |
State University of New York at Buffalo
| 5 years |
| Dana Tanner | M | - |
The University of Alabama
| 3 years |
| James Daly | M | 62 |
State University of New York at Buffalo
| 6 years |
| Harry Patrick Barnum | M | - |
State University of New York at Buffalo
| 5 years |
| Elizabeth Johnson Higbie | M | - |
The University of Alabama
| 1 years |
| Paul S. Molnar | M | 68 |
State University of New York at Buffalo
| 6 years |
| Franklin Inzer Brown | M | - |
The University of Alabama
| 7 years |
| Leith Martin | M | - |
The University of Alabama
| 7 years |
| Brad Alford | M | - |
The University of Alabama
| 2 years |
| Francesca Allen Smitherman | F | - |
The University of Alabama
| 5 years |
| Zach Musso | M | - |
The University of Alabama
| 4 years |
| Jim Badke | M | - |
State University of New York at Buffalo
| 4 years |
| Randeep Brar | M | - |
The University of Alabama
| 2 years |
| Robert Payne | M | - |
The University of Alabama
| 4 years |
| Troy L. Kilpatrick | M | - |
The University of Alabama
| 4 years |
| Alan Gaylor | M | - |
The University of Alabama
| 4 years |
| John Brodfuehrer | M | 66 |
State University of New York at Buffalo
| 4 years |
| Gregg Polinsky | M | - |
The University of Alabama
| 9 years |
| Wendy Adams | F | - |
The University of Alabama
| 4 years |
| Christopher Flint | M | - |
The University of Alabama
| 3 years |
| Sunny Chukwudi Obidegwu | M | - |
State University of New York at Buffalo
| 4 years |
| Donny Donald | M | - |
The University of Alabama
| 4 years |
| Brent Akers | M | - |
The University of Alabama
| 4 years |
| Harold Meckler | M | - |
State University of New York at Buffalo
| 3 years |
| William Gipson | M | 66 |
The University of Alabama
| 4 years |
| Dean Dillard | M | - |
The University of Alabama
| 4 years |
| Douglas Luckett | M | - |
The University of Alabama
| 4 years |
| Gyeong-Seon Son | M | 60 |
The University of Alabama
| 4 years |
| Jung-Mi Kim | M | 64 |
The University of Alabama
| 3 years |
| Tracy Rosser | M | 58 |
The University of Alabama
| 5 years |
| Gregory W. Nelson | M | 61 |
The University of Alabama
| 4 years |
| Donald Phil Maughan | M | - |
The University of Alabama
| 4 years |
| Joshua Mandell | M | 49 |
The University of Alabama
| 4 years |
| Eric Lynn | M | - |
State University of New York at Buffalo
| 4 years |
| Philip Francis Rongo | M | 62 |
State University of New York at Buffalo
| 4 years |
| Cathy Ogletree | F | - |
The University of Alabama
| 4 years |
| Richard E. Anthony | M | 77 |
The University of Alabama
| 5 years |
| Charles Scarborough | M | 61 |
The University of Alabama
| 4 years |
| Adrian Hughes | F | - |
The University of Alabama
| 4 years |
| Perry Edward Atkins | M | - |
State University of New York at Buffalo
| 4 years |
| Robert Black | M | 65 |
State University of New York at Buffalo
| 4 years |
| Bob Schorr | M | - |
State University of New York at Buffalo
| 3 years |
| Jason Harris | M | - |
The University of Alabama
| 4 years |
| Abdul Jalil bin Abdul Karim | M | 60 |
The University of Alabama
| 4 years |
| Kevin Centofanti | M | 64 |
State University of New York at Buffalo
| 6 years |
| Myra Roberts | F | - |
The University of Alabama
| 4 years |
| Jim Ferrare | M | - |
State University of New York at Buffalo
| 4 years |
| Evan G. Dick | M | 72 |
State University of New York at Buffalo
| 3 years |
| Craig Mezik | M | - |
The University of Alabama
| 4 years |
| Robert C. Ross | M | - |
The University of Alabama
| 4 years |
| Peter Jerome Grogan | M | - |
State University of New York at Buffalo
| 3 years |
| James M. Craig | M | 67 |
State University of New York at Buffalo
| 4 years |
| Lisa Williams | F | - |
The University of Alabama
| 4 years |
| Mark Bryant Tyson | M | - |
The University of Alabama
| 4 years |
| Jack Ross | M | 67 |
State University of New York at Buffalo
| 4 years |
| Joseph I. Rader | M | - |
State University of New York at Buffalo
| 4 years |
| Brett N. Blackwood | M | - |
The University of Alabama
| 3 years |
| Michael Calise | M | - |
State University of New York at Buffalo
| 4 years |
| James M. Proctor | M | - |
The University of Alabama
| 4 years |
| Brandon White | M | - |
The University of Alabama
| 4 years |
| George R. McCurdy | M | - |
The University of Alabama
| 4 years |
| Russell T. Henshaw | M | - |
The University of Alabama
| 4 years |
| Tammy Halcomb | F | - |
The University of Alabama
| 4 years |
| Heath Terry | M | - |
The University of Alabama
| 4 years |
| Richard Gluck | M | - |
State University of New York at Buffalo
| 4 years |
| Jamilus bin Mohamed Hussin | M | 80 |
State University of New York at Buffalo
| 1 years |
| David A. Dooley | M | - |
State University of New York at Buffalo
| 3 years |
| Kuo En Chang | M | - |
The University of Alabama
| 3 years |
| Francis J. Boggan | M | - |
State University of New York at Buffalo
| 4 years |
| Scott Peters | M | - |
The University of Alabama
| 4 years |
| Tom Griffith | M | - |
The University of Alabama
| 4 years |
| Mark Crosswhite | M | 61 |
The University of Alabama
| 4 years |
| Steven Cohen | M | - |
State University of New York at Buffalo
| 4 years |
| Lance Shoemaker | M | - |
The University of Alabama
| 4 years |
| David Oppenheimer | M | 67 |
State University of New York at Buffalo
| 4 years |
| Ryan N. Burgess | M | - |
The University of Alabama
| 4 years |
| W. Mark Dixon | M | - |
The University of Alabama
| 4 years |
| Laurann H. Stepp | F | - |
The University of Alabama
| 2 years |
| Shelley Bergman | F | - |
State University of New York at Buffalo
| 3 years |
| Howard A. Werman | M | - |
State University of New York at Buffalo
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John H. Eldridge
- Personal Network
